Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of L-arginine on epilepsy
IRCT201603078436N3Phase 3Completed
- Sponsor
- Neurology Research Center, Kerman University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in epilepsy, sponsored by Neurology Research Center, Kerman University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
arginine
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT201603078436N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201603078436N3.